Growing the love for investing
Results 1 - 10 of 3094 : 1 2 3 4 5 6 7 8 9 Next
The Dow's 3 Biggest Losers This Week
Here they are.
Have J&J's Approval Hopes Vanished?
Johnson & Johnson might have trouble sidestepping the competition.
The Meaningless Drug Approval That Could Cost the Industry Billions
Being able to use surrogate endpoints is important for drug developers.
Chelsea gets updated information from the FDA.
That's what phase 2 trials are for.
Are 3 Failed Phase 3 Trials Enough?
The NExUS between ESCAPE and MISSION is failure.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK